Navigation Links
Blood Pressure Drug Might Work Against MS

Research shows inflammation link between two disorders

MONDAY, Aug. 17 (HealthDay News) -- Dr. Lawrence Steinman has this seemingly crazy idea that a drug commonly used to combat high blood pressure can help prevent the damage done to nerve cells in multiple sclerosis.

But people in the know tend to listen carefully to the ideas of Steinman, a professor of neurology at Stanford University, because one of his ideas was crucial in the development of natalizumab (Tysabri), a now widely used medication that can reduce the incidence of relapses in multiple sclerosis (MS) by two-thirds.

Research exploring Steinman's latest brainstorm appears online Aug. 17 in the Proceedings of the National Academy of Sciences.

Steinman said he got his latest idea after he was prescribed the ACE inhibitor lisinopril (Zestril) for high blood pressure. When he put the drug name into his computer's search engines, vague references to a relationship between the drug's target, angiotensin, and multiple sclerosis started showing up.

An ACE (angiotensin-converting enzyme) inhibitor blocks the activity of an enzyme that converts angiotensin to a form that tightens blood vessels.

"Angiotensin constricts blood vessels in response to standing up, so we don't faint," he said. "Nerve cells are intrinsically tied up with blood vessel walls, and that pathway plays a role in inflammation."

Inflammation also plays a crucial role in multiple sclerosis, in which the body's immune system attacks the myelin sheath of nerve cells in the brain. "We can also argue that inflammation plays a role in hypertension," Steinman said.

Working with researchers from other institutions, he put the idea to a variety of tests, such as examining tissue from brain samples of people with MS. The studies showed significantly elevated levels of the cell receptors for angiotensin and the enzyme blocked by lisinopril and other ACE inhibitors.

But surely, an effect on MS of such widely used drugs should have been noticed by now? Not so sure, Steinman said. "Generally, one doesn't start taking an ACE inhibitor until about age 60," he said. "Multiple sclerosis is a disease that starts in early adulthood, so not many people in the early stages of MS are taking an ACE inhibitor."

Steinman would like to go directly to a human trial to test his proposal, but there are practical difficulties. "Who's going to pay for it?" he asked. A standard proof-of-concept study with about 200 patients would cost in the vicinity of $20 million. ACE inhibitors are as inexpensive as any prescription drug at this time, so pharmaceutical companies won't see any profits from financing a study, he said.

Steinman said he plans to apply to the U.S. National Institute of Neurological Disorders and Stroke for funding, but he acknowledges that "in general, NINDS doesn't have that kind of money."

In the meantime, basic research will continue, he said. "We are seeing the type of nerve cells that angiotensin reacts with, the mediators that are reducing inflammation," Steinman said. "This is an unexpected pathway of inflammation in MS."

"It's a very interesting proposal," said Patricia O'Looney, director of biomedical research at the National Multiple Sclerosis Society, which has financed some of the research. "The interest in MS is to find new strategies in order to control inflammation, what is the best way to control the pro-inflammatory molecules in MS."

There was some interest in studying the role of angiotensin in MS years ago, "but we didn't know much about the immune system 10 or 15 years ago," O'Looney said. "Now we can use state-of-the-art technology to examine the expression of proteins in human tissue. There could be a role of angiotensin in this inflammatory pathway. Perhaps by controlling these pathways we can actually shift the immune balance in a favorable way."

More information

All the aspects of MS are explored by the National Multiple Sclerosis Society.

SOURCES: Lawrence Steinman, M.D., professor, neurology, Stanford University, Stanford, Calif.; Patricia O'Looney, Ph.D., director, biomedical research, National Multiple Sclerosis Society, New York City; Aug. 17, 2009, Proceedings of the National Academy of Sciences, online

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mothers Immune System May Block Fetal Treatments for Blood Diseases
2. Cord Blood America Says Balance Sheet Significantly Strengthened in 2009
3. Heroes of Chemistry for saving teeth, clean water, new high blood pressure drug
4. Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
5. BD and PEPFAR Collaboration Will Improve Blood-Drawing Practices in Hospitals and Clinics in Sub-Saharan Africa
6. MRI Simulation of Blood Flow Helps Plan Childs Heart Surgery
7. Cold, Flu or Pneumonia? Answer May Lie in Blood Test
8. U.S. Navy Awards Entegrion Contracts for $4 Million for the Development of Critical Blood Products
9. Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity
10. Blood transfusion study: Less is more
11. Gut Hormone Could be Key to Blood Sugar
Post Your Comments:
Related Image:
Blood Pressure Drug Might Work Against MS
(Date:10/10/2015)... ... ... have to walk with crutches for the rest of my life," said an inventor from ... that would give me more independence and freedom would be amazing. This inspired me to ... developed the STRAP IN to enable an individual to walk with crutches without having to ...
(Date:10/10/2015)... ... , ... The Bank of America 500 NASCAR Sprint Cup Series race is ... defending race winner, Kevin Harvick, will battle it out for the checkered flag with ... the stars of the NASCAR Sprint Cup Series. As part of the opening ...
(Date:10/10/2015)... ... October 10, 2015 , ... Attending medical school and ... men, women and children. Depending on the school, the exact details of the ... field. , Students in a medical school must complete undergraduate classwork and requirements ...
(Date:10/10/2015)... PA (PRWEB) , ... October 10, 2015 , ... ... Wigrizer, Brecher & Miller is pleased to be recognized by The National Law ... This list acknowledges the 50 law firms across the United States who obtained ...
(Date:10/9/2015)... ... October 09, 2015 , ... Doctors on Liens ... in Fresno , to provide highly needed medical care to personal injury victims. ... medical providers to diagnose, document and treat the variety of conditions ailing them. ...
Breaking Medicine News(10 mins):
... Calif., Sept. 8 (Nasdaq: WHRTD ) - World ... the Company received a NASDAQ Staff Deficiency Letter indicating that the ... This rule requires the Company to maintain a minimum of 500,000 ... Subsequently on September 4, 2009, the Company received a letter from ...
... , WESTON, Fla., Sept. 8 Kidz-Med ... today announced the receipt of a follow-up purchase order of equal ... and closed a large purchase of Kidz-Med,s ... Company,s history. , , Dr. Christopher ...
... , Expanding facility will provide training ... the Highbridge area of the Bronx , , ... officially open the newest addition to the non-profit agency on September ... cutting ceremony at the facility. Located at 1438 Ogden Ave., ...
... NEW YORK, NY, Sept. 8 /PRNewswire-FirstCall/ - (OTCBB: ... company that identifies, acquires, and develops novel drug ... today announced it has appointed Dr. Anders Boegh ... Dr. Boegh Jensen will contribute his considerable expertise ...
... results for recipients in study , TUESDAY, Sept. 8 ... organ donors may help preserve the quality of their ... Most transplanted kidneys come from donors whose hearts are ... chain of events that can damage organs and increase ...
... Ohio Hairstylists may have a unique opportunity to ... according to a small, exploratory study. More than ... older clients often or always shared their problems during ... to notice when their older clients are starting to ...
Cached Medicine News:
(Date:10/9/2015)... 2015 Eli Lilly and Company (NYSE: LLY ... approximately 50 new jobs to its research and development presence ... York, New York . --> ... will include a translational immuno-oncology hub and a Lilly "portal," ... access to cutting-edge drug discovery capabilities, including chemistry and lead ...
(Date:10/9/2015)... 2015 Ansun BioPharma announced a presentation at ... ) regarding the compassionate use of DAS181 under an ... who was co-infected with influenza and parainfluenza (Abstract # ... O 2 requirement was reduced and the patient,s ... go off the respirator on day 5. Between day ...
(Date:10/9/2015)... El ,JCA-Mauvernay Award 2015, se ha otorgado a los ... Junko Takita    --> El ,JCA-Mauvernay Award 2015, ... y Junko Takita    --> ... a los doctores Yutaka Kondo y ... global con sede enSuiza, presentará el ,JCA-Mauvernay Award, el 10 de octubre a ...
Breaking Medicine Technology:
... AstraZeneca (NYSE:,AZN) today announced that it submitted ... Food and Drug Administration (FDA) for approval of ... for the treatment of patients with Chronic Obstructive,Pulmonary ... long-term,maintenance treatment of asthma in patients 12 years ...
... Inc. ("QI"),announces the commencement of a Phase I/II ... a novel anti-cancer vaccine/immunotherapy that will,be used on ... accepted,into the study have previously failed to respond ... QI has commissioned,the study to be done by ...
Cached Medicine Technology:
... ideal where space is restricted. Due to ... and flexible in every situation. For many ... be positioned optimally on the JUPITER during ... the operating theatre, the high level of ...
... schaerer axis 800 operating ... designed for those disciplines ... access. The stability, the ... the offset positioned telescoping ...
... words "mobile operating table" literally! The Alphastar 1132 ... of a general purpose operating table - is ... operations, a cable connected hand control, an IR-hand ... there is a control panel at the top ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
Medicine Products: